Results 221 to 230 of about 80,770 (310)

HBAC: Hierarchical‐Based Access Control Model for Storage Management in Data Lake Environments

Software: Practice and Experience, Volume 56, Issue 4, Page 445-461, April 2026.
ABSTRACT Background Traditional storage systems typically use simple access control models that manage permissions at the user or group level. These models, however, are not well suited for data lake environments, where large‐scale and diverse datasets must be accessed concurrently by users across multiple hierarchical levels, and they also have many ...
Yisac Hong, Myeong‐Seon Gil, Sanghun Lee, Yang‐Sae Moon   +3 more
wiley   +1 more source

Non-profit research: an insight into the management and monitoring of clinical trials in Italy. [PDF]

Glob Reg Health Technol Assess
Tizi F, Appolloni V, Bonifacio B, Tommasi S, Lega S, Cagnazzo C.   +5 more
europepmc   +1 more source

Rationale and Design of the MIA Trial: A Proof‐of‐Concept Study of Minimally Invasive Autopsy in an Infectious Cause of Death in a Scandinavian ICU Setting

APMIS, Volume 134, Issue 4, April 2026.
ABSTRACT It remains a challenge to obtain well‐preserved tissue samples from deceased patients as access to regular autopsy is limited. Minimally invasive autopsy (MIA) is a potential alternative to the complete diagnostic autopsy because of its efficacy in providing non‐autolyzed tissue samples and its increased acceptability amongst the bereaved. The
Fridtjof Gjerdrum Helgesen, Birgitte Grønkær Toft, Camilla Musaeus Donato, Ulf Gøttrup Pedersen, Thomas Hildebrandt, Xiaohui Chen Nielsen, Eric Santoni‐Rugiu, Gro Linno Willemoe, Lothar Wiese, Henning Bay Nielsen   +9 more
wiley   +1 more source

Vulcano island: the new high resolution digital surface model post 2021-2022 volcanic unrest. [PDF]

Sci Data
Bisson M, Gianardi R, Iacono F, Madonia P, De Astis G, Spinetti C.   +5 more
europepmc   +1 more source

Clinical Trial: Early Nivolumab Addition to Regorafenib in Patients With Hepatocellular Carcinoma in Second‐Line (The GOING Trial)

Alimentary Pharmacology &Therapeutics, Volume 63, Issue 7, Page 955-966, April 2026.
In the phase I/IIa GOING trial, an add‐on strategy with regorafenib followed by nivolumab showed a manageable safety profile and meaningful clinical activity in second‐line hepatocellular carcinoma, with a median overall survival of 25 months and 45% three‐year survival in sorafenib‐experienced patients.
Marco Sanduzzi‐Zamparelli, Ana Matilla, José Luis Lledo, Sergio Muñoz‐Martínez, María Varela, Mercedes Iñarrairaegui, Christie Perelló, Beatriz Mínguez, Neus Llarch, Laura Márquez, Antonio Guerrero, Gemma Iserte, Andrés Castaño‐García, Laura Carrión, Marta Fortuny, Jordi Rimola, Ángeles García‐Criado, Gema Domenech, Ferran Torres, José Rios‐Guillermo, Loreto Boix, Esther Samper, Àngels Kateb, Jordi Bruix, Maria Reig   +24 more
wiley   +1 more source

GTP cycling protein (GCP): An ancient player for allosteric gatekeeping. [PDF]

mLife
Liu JL.
europepmc   +1 more source

Exploratory Analysis of Liraglutide Effects on Obstructive Sleep Apnea and Health‐Related Quality of Life in Individuals With Obesity and COPD: A Secondary Analysis of a Randomised Controlled Trial

Clinical Obesity, Volume 16, Issue 2, April 2026.
ABSTRACT Obstructive sleep apnea (OSA) is associated with chronic obstructive pulmonary disease (COPD) and obesity, and all three are linked to reduced health‐related quality of life (HRQoL). Coexistence of OSA and COPD increases morbidity and mortality compared to each condition alone.
Sofie Krogh Wolsing, Ayse Dudu Altintas Dogan, Claus Bogh Juhl, Søren Hess, Torben Tranborg Jensen, Else‐Marie Bladbjerg, Ole Hilberg   +6 more
wiley   +1 more source

Rationale and design of a parallel randomised trial of a plant‐based intensive lifestyle intervention for diabetes remission: The REmission of diabetes using a PlAnt‐based weight loss InteRvention (REPAIR) trial

Diabetes, Obesity and Metabolism, Volume 28, Issue 4, Page 2627-2641, April 2026.
Abstract Aims As type 2 diabetes (T2D) continues to rise globally and remains a major driver of cardiovascular disease, its remission has emerged as a therapeutic target. Current evidence supports bariatric surgery and low‐calorie diets with meal replacements.
Brighid McKay, Dayana El Chaar, Melanie Paquette, Michael Vallis, Diana Sherifali, Paul Oh, Susan Marzolini, Kaberi Dasgupta, Gillian Booth, Mike Lean, Hertzel C. Gerstein, Jordi Salas‐Salvadó, Jacqueline L. Beaudry, Christopher P. F. Marinangeli, Russell J. de Souza, Lawrence A. Leiter, Cyril W. C. Kendall, David J. A. Jenkins, John L. Sievenpiper, Laura Chiavaroli   +19 more
wiley   +1 more source

Metacognition and cognitive dysfunction in post-COVID condition. [PDF]

Front Psychol
Oliver-Mas S, Delgado-Alonso C, Díez-Cirarda M, Catricalà E, Cuevas C, Valles-Salgado M, Barroso Y, López-Carbonero JI, Alcalá Ramírez Del Puerto JM, Cappa SF, Matias-Guiu JA.   +10 more
europepmc   +1 more source

Protein nanoparticles assemble in plants, display antigenic viral peptides, and produce an epitope‐specific immune response

The FEBS Journal, Volume 293, Issue 7, Page 1891-1907, April 2026.
Current methods to control porcine reproductive and respiratory syndrome, a disease affecting pigs, are insufficient and a safer, more effective vaccine is needed. This study describes the design and plant production of a self‐assembling protein nanoparticle vaccine candidate against this disease.
Jordan T. VanderBurgt, Richard Strasser, Hong Zhu, Angelo Kaldis, Christopher P. Garnham, Rima Menassa   +5 more
wiley   +1 more source